文献速递肾癌与肾肿瘤

三维模型辅助微创肾部分切除术:比较研究的系统评价与Meta分析

Three-dimensional Model-assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies.
PubMed 文献 · Eur Urol Oncol · 2022-10-07

该系统评价与Meta分析检索至2021年12月,纳入17项比较研究,评估三维模型对微创保留肾单位手术的影响。三维技术显著降低整体缺血率、输血率、集合系统开放率及出血量,并促进更多剜除,但肿瘤学与功能结局无显著改善。

要点

  • 三维技术显著降低整体缺血率(OR 0.22,95%CI 0.07-0.76;p=0.02)和输血率(OR 0.20,95%CI 0.07-0.56;p<0.01)。
  • 三维技术促进更多剜除(OR 2.54,95%CI 1.36-4.74;p<0.01),减少集合系统开放(OR 0.36,95%CI 0.15-0.89;p=0.03)。
  • 三维技术与出血量减少相关(MD 23.1 ml,95%CI 31.8-14.4;p<0.01),但肿瘤学与功能结局无显著改善。

核心结论

  • 三维引导用于保留肾单位手术与较低的肾脏损伤和手术损伤发生率相关,具体表现为更少的非肿瘤肾实质暴露于缺血或被切除,以及更少的集合系统开放。
  • 然而,三维技术的使用并未导致肿瘤学或功能结局的显著改善。

研究设计与样本

  • 系统评价与Meta分析,检索Medline(PubMed)、Embase(Ovid)、Scopus和Web of Science数据库,检索时间为2021年12月。
  • 方案在PROSPERO注册(CRD42022300948),检索策略采用PICOS标准,文章筛选遵循PRISMA指南。
  • 初步电子检索识别450篇论文,其中17篇符合纳入标准并纳入分析。
  • 二分类结局采用Mantel-Haenszel法,结果以比值比(OR)汇总;连续数据采用逆方差法,结果以均数差(MD)报告。
  • 所有效应估计均报告95%置信区间(CI),p≤0.05认为有统计学意义;所有分析使用R软件及meta包进行。

主要发现

  • 三维技术的使用导致整体缺血率显著降低(OR 0.22,95%CI 0.07-0.76;p=0.02)。
  • 三维技术促进更频繁的剜除(OR 2.54,95%CI 1.36-4.74;p<0.01),并减少集合系统开放(OR 0.36,95%CI 0.15-0.89;p=0.03)。
  • 三维技术与出血量减少相关(MD 23.1 ml,95%CI 31.8-14.4;p<0.01)。
  • 三维引导用于保留肾单位手术与输血率显著降低相关(OR 0.20,95%CI 0.07-0.56;p<0.01)。
  • 转为根治性肾切除术率、轻微和重大并发症率、肾小球滤过率变化及手术切缘均无显著差异(所有p>0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Use of three-dimensional (3D) guidance for nephron-sparing surgery (NSS) has increased in popularity, especially for laparoscopic and robotic approaches. Different 3D visualization modalities have been developed as promising new tools for surgical planning and intraoperative navigation. OBJECTIVES: To summarize and evaluate the impact of 3D models on minimally invasive NSS in terms of perioperative, functional, and oncological outcomes. EVIDENCE ACQUISITION: A systematic literature search was conducted in December 2021 using the Medline (PubMed), Embase (Ovid), Scopus, and Web of Science databases. The protocol was registered on PROSPERO (CRD42022300948). The search strategy used the PICOS (Population, Intervention, Comparison, Outcome, Study design) criteria and article selection was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The risk of bias and the quality of the articles included were assessed. A dedicated data extraction form was used to collect the data of interest. Meta-analysis was performed using the Mantel-Haenszel method for binary outcomes, with results summarized as the odds ratio (OR), and the inverse variance method for continuous data, with results reported as the mean difference (MD). All effect estimates are reported with the 95% confidence interval (CI) and p ≤ 0.05 was considered statistically significant. All analyses were performed using R software and the meta package. EVIDENCE SYNTHESIS: The initial electronic search identified 450 papers, of which 17 met the inclusion criteria and were included in the analysis. Use of 3D technology led to a significant reduction in the global ischemia rate (OR 0.22, 95% CI 0.07-0.76; p = 0.02) and facilitated more frequent enucleation (OR 2.54, 95% CI 1.36-4.74; p < 0.01) and less frequent opening of the collecting system (OR 0.36, 95% CI 0.15-0.89; p = 0.03) and was associated with less blood loss (MD 23.1 ml, 95% CI 31.8-14.4; p < 0.01). 3D guidance for NSS was associated with a significant reduction in the transfusion rate (OR 0.20, 95% CI 0.07-0.56; p < 0.01). There were no significant differences in rates of conversion to radical nephrectomy, minor and major complications, change in glomerular filtration rate, or surgical margins (all p > 0.05). CONCLUSIONS: 3D guidance for NSS is associated with lower rates of detriment and surgical injury to the kidney. Specifically, a lower amount of nontumor renal parenchyma is exposed to ischemia or sacrificed during resection, and opening of the collecting system is less frequent. However, use of 3D technology does not lead to significant improvements in oncological or functional outcomes. PATIENT SUMMARY: We reviewed the use of three-dimensional tools for minimally invasive surgery for partial removal of the kidney in patients with kidney cancer. The evidence suggests that these tools have benefits during surgery, but do not lead to significant improvements in cancer control or functional outcomes for patients.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Piramide F, Kowalewski KF, Cacciamani G, et al. Three-dimensional Model-assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies. Eur Urol Oncol. 2022. PMID: 36216739. doi:10.1016/j.euo.2022.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。